Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Volume Kinetics of Hyperoncotic Albumin in Burn Patients
NCT02952378Phase 4Completed
- Start
- Oct 2016
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of albumin (human) in burn injury (2 arms). Primary endpoint: Plasma volume at 5 hours. Started Oct 2016; status: completed.
02
Drugs
albumin (human)
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02952378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02952378.